- Home
- CMCL vs CTMX Comparison
CMCL vs CTMX Comparison
Compare CMCL & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMCL
- CTMX
- Stock Information
- Founded
- CMCL 1992
- CTMX 2008
- Country
- CMCL Jersey
- CTMX United States
- Employees
- CMCL N/A
- CTMX N/A
- Industry
- CMCL Precious Metals
- CTMX Biotechnology: Pharmaceutical Preparations
- Sector
- CMCL Basic Materials
- CTMX Health Care
- Exchange
- CMCL Nasdaq
- CTMX Nasdaq
- Market Cap
- CMCL 523.5M
- CTMX 596.2M
- IPO Year
- CMCL N/A
- CTMX 2015
- Fundamental
- Price
- CMCL $26.47
- CTMX $4.21
- Analyst Decision
- CMCL Strong Buy
- CTMX Strong Buy
- Analyst Count
- CMCL 1
- CTMX 5
- Target Price
- CMCL $28.00
- CTMX $5.80
- AVG Volume (30 Days)
- CMCL 298.3K
- CTMX 3.4M
- Earning Date
- CMCL 11-10-2025
- CTMX 11-06-2025
- Dividend Yield
- CMCL 2.11%
- CTMX N/A
- EPS Growth
- CMCL 432.25
- CTMX 263.20
- EPS
- CMCL 1.92
- CTMX 0.49
- Revenue
- CMCL $204,738,000.00
- CTMX $141,100,000.00
- Revenue This Year
- CMCL $47.83
- CTMX N/A
- Revenue Next Year
- CMCL $3.20
- CTMX N/A
- P/E Ratio
- CMCL $13.81
- CTMX $8.61
- Revenue Growth
- CMCL 28.06
- CTMX 18.01
- 52 Week Low
- CMCL $8.81
- CTMX $0.40
- 52 Week High
- CMCL $38.75
- CTMX $4.62
- Technical
- Relative Strength Index (RSI)
- CMCL 30.50
- CTMX 74.75
- Support Level
- CMCL $26.36
- CTMX $3.22
- Resistance Level
- CMCL $29.00
- CTMX $3.50
- Average True Range (ATR)
- CMCL 1.90
- CTMX 0.33
- MACD
- CMCL -0.77
- CTMX 0.06
- Stochastic Oscillator
- CMCL 1.50
- CTMX 75.00
About CMCL Caledonia Mining Corporation Plc
Caledonia Mining Corp PLC is a gold exploration, development, and mining company. The company's segment includes Blanket, South Africa, Bilboes Oxide mine, and E&E projects. The company generates the majority of its revenue from the Blanket project. The Blanket Mine is located in the south-west of Zimbabwe and operates at a depth of approximately 750 meters below the surface. The company's project includes Maligreen and Motapa.
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.